BBOT
BridgeBio Oncology Therapeutics Inc.NASDAQHealthcare$8.91-1.33%ClosedMarket Cap: $713.1M
As of 2026-04-06
Insider Statistics (Q1 2026)
Purchases
8
Sales
0
Buy/Sell Ratio
0.00
Total Bought
$0.00
Total Sold
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Thu Mar 26 | Lebowitz Peter F | Sell | 0 | $0.00 | 0 | |
| Thu Mar 26 | Lebowitz Peter F | director | Sell | 63,350 | $8.72 | 63,350 |
| Thu Mar 12 | Beltran Pedro | officer: Chief Scientific Officer | Sell | 210,000 | $10.19 | 210,000 |
| Thu Mar 12 | Beltran Pedro | officer: Chief Scientific Officer | Sell | 46,670 | $0.00 | 46,670 |
| Thu Mar 12 | Ben Yong | officer: Chief Med & Dev Officer | Sell | 210,000 | $10.19 | 210,000 |
| Thu Mar 12 | Ben Yong | officer: Chief Med & Dev Officer | Sell | 46,670 | $0.00 | 46,670 |
| Thu Mar 12 | Mehra Uneek | officer: Chief Financial Officer | Sell | 105,000 | $10.19 | 105,000 |
| Thu Mar 12 | Mehra Uneek | officer: Chief Financial Officer | Sell | 23,330 | $0.00 | 23,330 |
| Mon Jan 05 | Wallace Eli M. | director, officer: Chief Executive Officer | Sell | 1,114,400 | $12.52 | 1,114,400 |
| Fri Dec 12 | Wallace Eli M. | director, officer: Chief Executive Officer | Sell | 1,114,400 | $12.44 | 500,000 |
| Thu Oct 16 | BridgeBio Pharma LLC | 10 percent owner | Sell | 784,720 | $0.00 | 14,589,846 |
| Mon Oct 06 | Wallace Eli M. | director, officer: Chief Executive Officer | Sell | 1,614,400 | $12.44 | 1,614,400 |